A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4)-Reference-Cited by-同舟云学术

A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4)

Published:2015-07-23 Issue:4 Volume:126 Page:500-503
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Choi Philip Young-Ill¹^ORCID,Roncolato Fernando²,Badoux Xavier²,Ramanathan Sundra²,Ho Shir-Jing²,Chong Beng H.¹²

Affiliation:

1. St George Clinical School, University of New South Wales, Kogarah, NSW, Australia; and

2. Department of Haematology, St George Hospital, Kogarah, NSW, Australia

Abstract

Key Points Triple therapy is well tolerated and effective in patients with chronic ITP. Relapse free survival was 92% for responders after 12 months and 76% after 24 months.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/126/4/500/1390531/500.pdf

Reference22 articles.

1. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.;Rodeghiero;Blood,2009

2. The ITP syndrome: pathogenic and clinical diversity.;Cines;Blood,2009

3. Cellular immune mechanisms in autoimmune thrombocytopenic purpura: An update.;Coopamah;Transfus Med Rev,2003

4. The role of autoreactive T-cells in the pathogenesis of idiopathic thrombocytopenic purpura.;Kuwana;Int J Hematol,2005

5. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP.;McMillan;Blood,2004

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab versus Splenectomy in Chronic Primary ITP: Experience of a Single Hematology Clinic;Mediterranean Journal of Hematology and Infectious Diseases;2024-02-29

2. Thrombopoietin receptor agonist and rituximab combination therapy in patients with refractory primary immune thrombocytopenia;Blood Coagulation & Fibrinolysis;2024-02-14

3. Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI);Journal of Clinical Medicine;2023-10-10

4. Early immunomodulation in immune thrombocytopenia—A report of the ICIS meeting in Lenzerheide, Switzerland 2022;British Journal of Haematology;2023-09-21

5. Primary and secondary immune thrombocytopenia (ITP): Time for a rethink;Blood Reviews;2023-09